3rd Annual
Orphan Drugs Congress

21 - 22 May 2014, Barcelona, Spain

We would like to thank our partners and sponsors for supporting us and the whole event, our speakers and advisers for contributing with their knowledge, experience and strategies, and all delegates for finding the time to join us in Barcelona, Spain. We are delighted that you chose to attend the Orphan Drugs Congress and we had the chance to meet you there and talk to you.

If you have any further questions or you are just eager to learn more about our upcoming events, do not hesitate to contact us. We would also appreciate your comments and suggestions that could help us improve our future conferences.

Thank you for your support and contribution, we look forward to seeing you again next year!


3rd Annual ORPHAN DRUGS FORUM

Special features
  • working with patients and regulatory bodies
  • the granting of orphan designations
  • austerity-conscious governments
  • the essential role of patients
  • cost-cutting pressure
  • a different approach
  • attractiveness

 

Come and listen to real life case studies, discover innovative approaches
and benefit from interactive discussions with your peers to benchmark your experiences


 
KEY TOPICS
  • Discuss how to improve processes for designation and speed up approval processes
  • Find out National Authorities’ interpretation of orphan drugs legislation and its impact on drug development
  • Learn how to effectively prepare for commercialization within Europe, the US and beyond
  • Explore the relevance of Patient Registries in the development of clinical research
  • Exchange knowledge on how to maximize partnerships and alliances
  • Examine the essential role of patient organisations in promoting access to treatment

Who will you meet

From Pharmaceutical Companies: CEOs, Presidents, VPs, Directors and Heads/Managers of (within sectors – Oncology, CV, Respiratory, Auto- Immune, etc):

  • (Orphan) Drug Discovery/Development
  • Therapeutic Development
  • Marketing & Medical Affairs
  • Business Unit
  • Regulatory Affairs
  • External Affairs
  • Market Access

From Biotechs:
  • CEOs
  • CMOs
  • CSOs

Together with:
  • Regulatory Bodies
  • HTA agencies
  • Academics
  • Research centres

 DISCOUNTED TRAVEL WITH LUFTHANSA
Official Airline Partner

Lufthansa
Austrian
Lufthansa group
Swiss
time to event
Contact us
 Michaela
Michaela Hubcikova
Marketing Manager
Fleming Europe
T: +421 257 272 162
F: +421 255 644 490

Venue
diagonal hotel
 
Hotel Silken Diagonal
Avenida Diagonal, 205
08018. Barcelona, Spain
T: +34 934 895 300
 
PostConferenceRep